Search 

Arcus Ventures was founded in 2007 and is based in New York City. Arcus Ventures is currently investing from its second fund, which had a first close of $36m in 2014 and is targeting a raise of $100m. The firm typically invests $2-5 million. Arcus invests primarily in the USA but is also open to considering opportunities in Canada.

ASTEC is a Tokyo-based, accelerator-type investment firm focused on company creation and seed-stage investment. We have been solely investing in Japan but now plans to launch a new fund, together with Tokyo-based FinTech Global Capital, that also invests in other geography leveraging our Japan connection, both academic inventions and pharmaceutical companies. ASTEC deeply gets involved with the management of its portfolio companies and represents some of them for BD activities.

Arizona’s bioscience and health care industry benefits from strong relationships with major institutions, hospitals, private firms and the state's public universities. CNBC ranks the state second nationwide in availability of skilled workforce, and biomedical jobs are growing three times faster than the national average.  In addition to our aggressive incentive programs, Arizona is committed to attracting and supporting quality companies through competitive tax policies and has demonstrated a continued trend of reducing property, individual sales and corporate income tax rates.  An example of some of the key programs and incentives for the biosciences includes:

• AZ Innovation Challenge – $3 million ($1.5 million twice yearly) for technology commercialization to the world’s most promising technology ventures. Awards range from $100,000 to $250,000 per company.

• Angel Investment Tax Credit - provides tax credits up to 35% for investors who make capital investment in small businesses certified by the Arizona Commerce Authority (ACA).   

• Arizona Innovation Accelerator Fund - an $18.2 million loan participation program to stimulate financing of small businesses and manufacturers by providing debt financing up to $2 million.  Recognized by the US Treasury as a Best Practice model of its kind

• R&D Tax Credit/Refund – refundable and non-refundable programs for increased R&D activities.  Income tax credits up to 34% for qualified expenses. Up to 75% of the excess tax credit can be refunded.

Baxter Ventures is the strategic venture arm of Baxter International Inc. that was formed in 2011 and is based in Deerfield, Illinois. The firm is currently making equity investments out of a $200 Million fund with allocations generally falling in the $3-$5 million range. The firm is looking in invest in companies who have previously or are currently in the process of securing investment from other institutional investors. The firm is willing to look globally for investment opportunities and plans to make approximately 2 new investments over the next 6-9 months.